by website | News and Updates, Research
New Physical Exercise study published in November, 2024 issue of the Journal of the Peripheral Nervous System The results of a TIN-sponsored study to determine the effects of exercise on the progression of CMT1X, using a mouse model of CMT1X, was first published as...
by website | News and Updates
For Steve O’Donnell, founder of Therapies for Inherited Neuropathies, those are words to live by. He calls them his life’s slogan. The slogan helps him self-motivate to spread awareness of Charcot Marie Tooth disease and to raise money for CMT research. It’s guided...
by website | News and Updates
The sponsor of the study is NMD Pharma A/S. If you’re living with Charcot-Marie-Tooth (CMT) disease, specifically CMT1 or CMT2 subtypes you may be eligible to participate in an exciting new clinical trial. NMD Pharma, a biotechnology company, has received approval...
by website | News and Updates
Mario Bortolozzi, Ph. D. I am an associate Professor in Biophysics at the Department of Physics and Astronomy “G. Galilei” at the University of Padua in Italy. Following my studies in Physics at the same university, I earned my doctoral degree in...
by website | News and Updates
The TIN CUP for CMT Therapies for Inherited Neuropathies (TIN) is a fully accredited 501(C)3 nonprofit whose sole focus is dedicated to identifying and advancing research and projects that bring solutions and treatments to Charcot-Marie-Tooth patients....
by website | News and Updates
Email from CMT Patient from June 2023 Hello Mr. O’Donnell, It is a pleasure to be put in touch with you. I am a 39 year old man with 1A who has been working with Mike for about a year. Prior to working with him, I had a six year period of living with constant...
